A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.

Clinical trial NCT07375758 · RECRUITING

Trial details

NCT number: NCT07375758
Sponsor: Beijing Mabworks Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immunoglobulin A Nephropathy

Start date: 2026-02-05
Primary completion: 2028-06-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.